TITLE

Stem cells in myocardial infarction: from bench to bedside

AUTHOR(S)
Möllmann, Helge; Nef, Holger; Elsässer, Albrecht; Hamm, Christian
PUB. DATE
March 2009
SOURCE
Heart;Mar2009, Vol. 95 Issue 6, p508
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66105978

 

Related Articles

  • Stem Cell Therapy for Myocardial Infarction 2001-2013 Revisited. Edlinger, Christoph; Schreiber, Catharina; Wernly, Bernhard; Anker, Alexandra; Ruzicka, Katja; Jung, Christian; Hoppe, Uta; Lichtenauer, Michael // Stem Cell Reviews & Reports;Oct2015, Vol. 11 Issue 5, p743 

    Stem cell therapy for ischemic heart disease was an emerging concept in the early 2000s. First hopes were largely overshadowed by rather inconsistent results in human trials conducted in the middle of the decade. We aimed at investigating how the field of stem cell research expanded worldwide...

  • Stem cell therapy for myocardial infarction. Hyun-Jae Kang; Hyo-Soo Kim; Young-Bae Park // CMAJ: Canadian Medical Association Journal;8/31/2004, Vol. 171 Issue 5, p442 

    Provides information on the use of stem cell therapy for patients with myocardial infarction. Findings of clinical trials conducted on stem cell therapy; Discussion on the study conducted on autologous stem cells derived from skeletal myoblast, bone marrow, and peripheral blood; Outcome of a...

  • Tracking of stem cells in vivo for cardiovascular applications. Azene, Nicole; Yingli Fu; Maurer, Jeremy; Kraitchman, Dara L. // Journal of Cardiovascular Magnetic Resonance (BioMed Central);2014, Vol. 16 Issue 1, p1 

    In the past ten years, the concept of injecting stem and progenitor cells to assist with rebuilding damaged blood vessels and myocardial tissue after injury in the heart and peripheral vasculature has moved from bench to bedside. Non-invasive imaging can not only provide a means to assess...

  • Detection of homing-in of stem cells labeled with technetium-99m hexamethylpropyleneamine oxime in infarcted myocardium after intracoronary injection. Patel, Chetan D.; Agarwal, Snehlata; Seth, Sandeep; Mohanty, Sujata; Aggarwal, Himesh; Gupta, Namit // Indian Journal of Nuclear Medicine;Oct-Dec2014, Vol. 29 Issue 4, p276 

    Bone marrow stem cells having myogenic potential are promising candidates for various cell-based therapies for myocardial disease. We present here images showing homing of technetium-99m (Tc-99m) hexamethylpropyleneamine oxime (HMPAO) labeled stem cells in the infarcted myocardium from a pilot...

  • Cardiac stem cell therapy: progress from the bench to bedside. Lovell, Matthew J.; Mathur, Anthony // Heart;Oct2010, Vol. 96 Issue 19, p1531 

    In the rush to assess the role of stem cell therapy for cardiovascular disease the details of translation are easily overlooked. This review summarises the progress to date in translating the exciting preclinical results of cardiac repair into man and considers the questions that this area of...

  • Republished review: Cardiac stem cell therapy: progress from the bench to bedside. Lovell, Matthew J; Mathur, Anthony // Postgraduate Medical Journal;Aug2011, Vol. 87 Issue 1030, p558 

    In the rush to assess the role of stem cell therapy for cardiovascular disease the details of translation are easily overlooked. This review summarises the progress to date in translating the exciting preclinical results of cardiac repair into man and considers the questions that this area of...

  • Stem Cell Treatment of the Heart. Angelini, Paolo; Markwald, Roger R. // Texas Heart Institute Journal;2005, Vol. 32 Issue 4, p479 

    Stem cells are multipotent, undifferentiated cells capable of multiplication and differentiation. Preliminary experimental evidence suggests that stem cells derived from embryonic or adult tissues (especially bone marrow) may develop into myocardial cells. Some experts believe that this...

  • In This Issue.  // Molecular Therapy;Jul2009, Vol. 17 Issue 7, p1120 

    The article discusses various reports published with in the issue, including one on the real-time imaging of transplanted human embryonic stem cell from neural stem cell grafts, one on cell therapy for myocardial infarction and one on genetically-engineered bone marrow stromal cells to prevent...

  • Human mesenchymal stem cells safe for use in patients after MI.  // Cardiology Today;Jan2010, Vol. 13 Issue 1, p12 

    The article discusses a study on the safety of human mesenchymal stem cells in patient who suffered from myocardial infarction (MI), conducted by researchers led by J. M. Hare and published in a 2009 issue of the "Journal of the American College of Cardiology."

  • Blood Stem Cells and non-Hematological Clinical Practice: Pragmatics Before Therapeutics. Parker, Graham C. // Current Pharmaceutical Biotechnology;Feb2007, Vol. 8 Issue 1, p51 

    There is considerable interest in biological sources for replacement, repair, as well as vascularization of tissue. The remarkable properties of blood stem cells encourage interest in their therapeutic potential. But what are these properties, and how do they influence their clinical potential...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics